With NADPH as the electron donor, rat liver NADPH cytochrome P-450 reductase (NADPH:ferricytochrome oxidoreductase, EC 1.6.2.4) catalyzes the single-electron reduction of several quinone antibiotics to a semiquinone or free radical state. The benzanthraquinones adriamycin, daunorubicin, carminomycin, 7-O-methylnogalarol, and aclacinomycin A and the N-heterocyclic quinones streptonigrin and mitomycin C are activated to free radical intermediates which can transfer their single electron to molecular oxygen to form superoxide. The overall Km range for this electron transfer is 0.4 to 42.1 X 10-4 M. We postulate that the formation of the "site-specific free radical" intermediate is central to the cytotoxic action of these antibiotics.
An unusually high proportion of anticancer agents contain quinone groups. Such quinone-containing anticancer agents include adriamycin, daunorubicin, mitomycin C, streptonigrin, lapachol, and analogs of these agents. Although investigators have identified several potential biochemical sites of action for these drugs, preponderant evidence indicates that the agents act primarily by interfering with DNA and RNA replication (1) (2) (3) (4) .
We have established that these quinone agents are catalytically activated to a free radical state by a microsomal system requiring NADPH as an electron donor (5, 6) . Normal microsomes as well as microsomes from murine leukemia cells catalyze augmented oxygen consumption with the quinone antibiotics, indicative of free radical formation. By using effectors of this microsomal system we obtained indirect evidence that a flavoprotein catalyst of the microsomes was involved and that cytochrome P-450 was not. Iyanagi and Yamazaki (7) have shown that NADPH cytochrome P-450 reductase (NADPH: ferricytochrome oxidoreductase, EC 1.6.2.4) reduces quinone substrates to semiquinones; and Goodman and Hochstein (8) reported that NADPH cytochrome P-450 reductase catalyzes production of superoxide from adriamycin. In the present paper, we describe and characterize the catalysis of drug free-radical formation bhey -tochrome P-450 reductase from rat-iver microsomes and propose a mechanism for the cytotoxic action of these agents.
METHODS AND MATERIALS
Adriamycin, N-dimethyladriamycin, daunorubicin, N-acetyldaunorubicin, 7-iminodaunorubicin, aclacinomycin A, mitomycin C, streptonigrin, and lapachol were kindly provided by the Drug Synthesis and Chemistry Branch and the Natural Products Branch (Division of Cancer Treatment, National Cancer Institute, National Institutes of Health). Daunorubicinol (9) and adriamycin (Fe3+)4 (10) were prepared as described. Carminomycin was provided by G. F. Gause (Institute of New Antibiotics, Moscow). Rubidazone was supplied by Rene Maral (Rhone-Poulenc, Vitry-Sur-Seine, France). Nogalamycin, 7-O-methylnogarol, and steffimycin were provided by G. Neil (Upjohn Co.); and N-trifluoroacetyladriamycin-14-valerate (AD-32) and N-trifluoroacetyladriamycin (AD-41) were supplied by M. Israel, (Farber Cancer Center, Boston, MA).
NADPH cytochrome P-450 reductase was prepared from rat liver microsomes according to the method of Omura and Takesue (11) and further purified by calcium phosphate gel adsorption. The enzyme obtained from the DEAE-cellulose column step was dialyzed against 1 mM KPO4 buffer (pH 7.5), adsorbed onto calcium phosphate gel, and eluted in a batch with 0.4 M KPO4 buffer (pH 7.5). The homogeneity of the enzyme was established by disc gel electrophoresis at pH 9. (Table 1) . Saturation of the reaction occurred at 0.2 mM NADPH and no increase in oxygen consumption was seen up to 2 mM NADPH.
The oxygen consumption had a linear dependence on
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NADPH cytochrome P-450 reductase concentration, and boiled enzyme was inactive. The enzyme showed a maximum for augmented oxygen consumption in phosphate buffer at pH 8.0, whereas Tris buffer was less supportive of the reaction (Fig. 1) . Dependence on ionic concentration appeared to be another characteristic of the enzyme; it showed an optimum at 0.2 M phosphate (data not shown).
In addition to augmenting oxygen consumption, the quinone anticancer agents also stimulated NADPH oxidation by NADPH cytochrome P-450 reductase ( Table 2) .
Using the optimal conditions for oxygen consumption by the purified enzyme, we assayed quinone anticancer agents from the benzanthraquinone, N-heterocyclic quinone, and napthoquinone classes for activity as substrates. All the quinone agents stimulated oxygen consumption, and the characteristics of their stimulation fit Michaelis-Menten kinetics, yielding Km values ranging from 4 X 10-5 M to 4 X 10-3 M ( Table 3 ). The anthracycline antibiotics adriamycin and daunorubicin and their semisynthetic analogs were quite active. In addition to those agents listed in Table 3 for which kinetic constants were measured, the agents AD 32, AD 41, and lapachol also stimulated oxygen consumption but no kinetic constants were determined because of low solubilities of these substances. Because we previously determined that the anthracycline antibiotics (5) as well as other quinone antibiotics (6) are converted to free radical forms by microsomes, we analyzed the NADPH cytochrome P-450 reductase reaction with these agents for free radical formation by electron paramagnetic resonance spectrometry. In the presence of enzyme, NADPH, and quinone substrate, we observed the appearance of distinct and characteristic free radical signals for each quinone (Fig.  2) . Enzyme, NADPH, and the quinone were necessary for free radical formation; boiled enzyme was inactive. The observed g factors fell in a range of 2.002 to 2.003. Due to the transient nature of the signals, a high modulation amplitude was usually required and, consequently, hyperfine structure was not resolved except in the case of streptonigrin (data not shown). Free radical signals obtained from aclacinomycin A and streptonigrin persisted whereas the signal from mitomycin C was quite small and transient. The observed signals were similar to those obtained in reaction mixtures containing microsomes (6). Electron paramagnetic resonance spectra of NADPH cytochrome P-450 reductase-catalyzed formation of quinone anticancer agent free radicals. Reaction mixtures were the same as for oxygen measurements but drug concentration was 0.5 mM. The reactions were run in a stoppered quartz aqueous flat cell. The reactions were started by the addition of enzyme, and the cells were stoppered and scanned over a 50-gauss range. The control reaction mixture contained no drug. Zero reference line corresponds to 3380 gauss.
-DISCUSSION Nishibayashi et al. (12) postulated that NADPH cytochrome P-450 reductase catalyzes the one-electron reduction of quinones that Iyanagi and Yamazaki (7) showed occurred by a single-electron transfer through the flavoprotein to yield a semiquinone product. We have shown that quinone antibiotics of the benzanthraquinone, N-heterocyclic quinone, and napthoquinone families also function as single-electron receptors for NADPH cytochrome P-450 reductase electron transfer to yield free radical intermediates. The free radical forms of the antibiotics readily transfer their single electrons to molecular oxygen.
In previous investigations, Schwartz et al. (13) found that mitomycin C required microsomal reduction to become cytotoxic. Later, Iyer and Szybalski (3) confirmed the need for reduction before mitomycin C could crosslink DNA. White and White (14, 15) have shown that streptonigrin also is activated by cellular reduction. Investigators have suggested that superoxide radical, peroxide, or hydroxyl radical formed from semiquinones of mitomycin C (16), daunorubicin or adriamycin (8, 17) , or streptonigrin (15, 18, 19) may be responsible for the toxic action of these agents. However, these same cytotoxic products of oxygen reduction result from the biochemical reduction of other quinones. Such quinones as vitamin K and coenzyme Q are normal constituents of cells but can yield toxic oxygen products (20) . To protect the cellular machinery from superoxide and other reduced forms of oxygen, the mammalian cell contains elaborate defense mechanisms such as superoxide dismutase, glutathione reductase, catalase, peroxidase, and reactive structural cellular components.
The quinone antibiotics we have examined not only have the property to form free radicals, but they also bind with high affinity to DNA and other macromolecules. Through this binding alone, quinone agents produce biochemical consequences. For example, the anthracycline antibiotics adriamycin and daunorubicin can effectively inhibit DNA and RNA synthesis and other biochemical DNA processing by binding to template DNA (21) . This binding and distortion of the DNA occurs in vitro in purified assay systems but never results in damage to or breakage of the DNA strands. On the other hand, when living cells are treated with adriamycin or daunorubicin, they rapidly show signs of DNA damage (22, 23) . Apparently, cellular processes are necessary for damage to be inflicted on the DNA.
Because free radicals are highly reactive, we think that the free radical forms of the quinone antibiotics may act as the damaging agents to DNA and possibly to other macromolecules. We propose that the quinone agents are activated to free radical forms intracellularly by NADPH cytochrome P-450 reductase and other quinone reductases and bind to DNA as the free radical (Fig. 3) . Thereby, the highly reactive semiquinone form of the antibiotic is brought into close proximity to the doublestranded DNA. The semiquinone form of the antibiotic then may either react directly with the DNA strands or produce reactive oxygen species within the DNA helix which could damage the DNA. It is possible that the quinone antibiotics have affinities for other critical macromolecules (RNA, protein) which may be reactive sites for the free radical forms of the quinone antibiotics. Lown There are several lines of evidence that support the interaction, binding, and consumption of the anthracycline antibiotics in tissues and cells. In our early studies on the fate of tritiated daunorubicin administered to animals, we noted the acid-stable binding of tritiated daunorubicin to mouse tissues (26) . This suggested a covalent linkage of the nonextractable anthracycline antibiotic to tissue components. In addition, when animals or humans are given adriamycin or daunorubicin, only 50-60% of the parent compound and metabolites are recovered in the urine and bile (27, 28 (29) . This again suggested a covalent binding of the antibiotic to the tissues.
Data from the laboratory of Myers and coworkers (30) have shown that adriamycin produces clear evidence of in vvo free radical formation by the production of the lipid peroxidation product malonaldehyde in adriamycin-treated mice. In addition, deoxyaglycone metabolites of adriamycin, daunorubicin, and other anthracycline antibiotics result from an autoreductive cleavage of the unstable semiquinone free radical intermediate (unpublished data). Therefore, the appearance of the deoxyaglycone metabolites in vivo proves the in vivo formation of free radical intermediates of these quinone agents. Evidence from previous experimentation supports the theses that (i) anthracycline antibiotics form free radicals in vivo and in vitro and (ii) the anthracycline antibiotics apparently bind covalently to tissue components in vivo and in vitro.
Two characteristics seem necessary for cytoxocity of these drugs. First, the drug must be capable of biochemical activation to a free radical state. Second, the drug must have an affinity for an essential macromolecule, such as DNA, RNA, or other molecules. The quinone antibiotics and perhaps other agents comprise a class of xenobiotic substances that require activation by the intracellular machinery to produce a reactive intermediate state of "site-specific free radicals."
We have shown that NADPH cytochrome P-450 reductase, a component of mammalian microsomes, catalyzes the reduction of quinone anticancer agents to free radical forms; and we propose that these site-specific free radicals provide the mechanism for selective damage of essential cellular macromolecules and thereby cause cell damage and death.
